Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 15, 2026
USO's +26% Surge: Geopolitical Risks and the United States Oil Fund, LP (USO)

USO's +26% Surge: Geopolitical Risks and the United States Oil Fund, LP (USO)

Key Takeaways

  • USO surged approximately 26% over the last 30 days, driven by a sharp escalation in the US-Iran military conflict and renewed threats to critical oil transit chokepoints.
  • Over the last quarter, the ETF has been roughly flat but extraordinarily volatile, collapsing below $104 in early July before rebounding dramatically.
  • The primary catalyst has been the breakdown of the June 18 ceasefire agreement, which triggered a rapid repricing of geopolitical risk premium across crude oil markets.
  • Simultaneous threats to the Strait of Hormuz, the Red Sea, and the Caspian Pipeline Consortium terminal created a rare multi-front supply disruption scare.
  • Declining US Strategic Petroleum Reserve levels and near-record-low Cushing inventories have left the market with thinner buffers against supply shocks.
  • Oil's rally reflects a market dominated by supply-fear dynamics, even as structural demand forecasts point toward a more tempered long-term outlook.

United States Oil Fund, LP (USO) Overview and Portfolio Exposure

The United States Oil Fund, LP (USO) is a passively managed commodities ETF that seeks to track the daily percentage changes of the spot price of West Texas Intermediate (WTI) light, sweet crude oil delivered to Cushing, Oklahoma. Launched in April 2006 by USCF Investments, the fund achieves its objective primarily by holding near-month WTI crude oil futures contracts on the NYMEX, alongside cash, money market instruments, and swap agreements used for collateral and liquidity management.

USO typically maintains a concentrated portfolio of fewer than 10 core positions. Its largest holdings consist of front-month and second-month WTI crude oil futures contracts, with the balance allocated to cash equivalents held in government and institutional money market funds. The fund carries a net expense ratio of approximately 0.70% and manages assets under management (AUM) of roughly $2.2 billion. Because USO invests directly in futures rather than equities, it has no sector allocation in the traditional sense — its performance is almost entirely a function of WTI crude oil price movements, adjusted for the costs of futures roll yield and fund expenses. This direct commodity exposure makes USO one of the purest publicly traded instruments for expressing a view on US crude oil prices, and it also means the fund is highly sensitive to any development that moves the oil market. I also checked this using Tickeron’s AI Screener to see how the fund compares to other commodity vehicles.

United States Oil Fund, LP (USO) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, USO has posted a gain of approximately 26%, rallying from a closing price near $103.27 in early July to roughly $130.10. This move represents one of the fund's strongest monthly performances in years and reflects a violent repricing of geopolitical risk in global crude markets. The advance was not gradual — it was characterized by sharp daily swings, including multiple sessions where crude futures moved by 5% to 8% in a single day, as traders reacted to rapidly evolving military and shipping developments.

Over the last quarter, USO's trajectory has been far more complex. After trading above $131 in late May — reflecting elevated war premiums from the initial phase of the US-Iran conflict — the fund collapsed toward $103 by early July following the signing of a US-Iran memorandum of understanding (MOU) on June 18. That agreement reopened the Strait of Hormuz and triggered a rapid unwind of the geopolitical risk premium that had supported prices since late February. The subsequent breakdown of that ceasefire and the re-escalation of hostilities then drove the fund back to approximately the same level where it started the quarter. In net terms, USO has been roughly flat over the three-month window, but the path between those two endpoints has been among the most volatile in the fund's two-decade history. I ran a quick comparison on Tickeron’s AI Screener to put this volatility in context with peers.

Key Drivers Behind USO’s 30-Day Rally

The 30-day surge in USO has been driven almost entirely by geopolitical events in the Middle East and their implications for global crude oil supply. After the June 18 MOU briefly restored tanker traffic through the Strait of Hormuz and sent WTI below $70 per barrel, the agreement collapsed in early July. The United States resumed airstrikes against Iranian military targets for more than 10 consecutive days, while Iran retaliated with missile and drone attacks targeting Kuwait and US assets in the region. The rapid breakdown of diplomacy restored a substantial war premium to crude prices virtually overnight.

Compounding the Hormuz disruption, Iran-backed Houthi militants in Yemen threatened a maritime blockade of Saudi shipping in the Red Sea and the Bab el-Mandeb Strait. At least three Saudi tankers reversed course rather than risk passage, and shipowners began demanding sharply higher war-risk insurance premiums. Simultaneously, attacks on the Caspian Pipeline Consortium terminal on Russia's Black Sea coast disrupted crude exports from Kazakhstan, one of the world's largest non-OPEC producers. For a period in mid-to-late July, three separate major export corridors — the Persian Gulf, the Red Sea, and the Black Sea — were simultaneously under threat, leaving the market with few alternative supply routes.

These disruptions occurred against a backdrop of historically thin supply buffers. US commercial crude inventories at Cushing, Oklahoma, declined to their lowest levels in over a decade, while the Strategic Petroleum Reserve (SPR) has been drawn down to levels not seen since the early 2000s. With limited government stockpiles available to cushion a genuine supply loss, even modest disruptions have produced outsized price reactions. Hedge fund positioning also amplified the move: many speculative accounts had reduced bullish crude exposure after the June ceasefire, and the sudden return of supply risk triggered aggressive short covering into thinning summer liquidity.

Quarterly Performance and Shifting Catalysts

The quarterly picture reflects a market oscillating between peace and war. The late-May to late-June period was defined by the collapse of the geopolitical risk premium, as the June 18 US-Iran MOU reopened the Strait of Hormuz and allowed tanker traffic to resume. WTI fell from above $98 per barrel in late May to below $70 in early July, and USO shed more than 20% of its value in roughly six weeks as traders priced in a return to normal supply flows. OPEC+ also continued its gradual unwinding of voluntary production cuts during this period, adding to the perception of looser supply.

The July reversal was equally dramatic. The ceasefire's failure not only restored the war premium but did so in an environment where multiple supply corridors were threatened simultaneously — a far more precarious setup than the initial February-to-May conflict phase, which had been largely confined to the Strait of Hormuz. The diversification of risk across the Red Sea and Black Sea corridors has made the market more sensitive to disruption and less confident in its ability to reroute supply around any single chokepoint. Institutional ETF flows into USO surged during the rally, reflecting renewed investor appetite for crude oil exposure as a portfolio hedge against energy-driven inflation and geopolitical tail risk.

USO Outlook: Factors Investors Should Monitor

The trajectory of USO over the coming months will be overwhelmingly determined by developments in the US-Iran conflict and the status of maritime chokepoints in the Middle East. Any credible ceasefire agreement or diplomatic breakthrough — particularly one that reopens the Strait of Hormuz to normalized tanker traffic — would likely trigger a rapid unwind of the current war premium, similar to the pattern observed after the June 18 MOU. Conversely, an expansion of the conflict to directly impact production infrastructure, rather than only shipping, could drive prices substantially higher from current levels.

Beyond geopolitics, several structural factors merit attention. OPEC+ policy remains an important swing variable: the group has continued its gradual production increases, but much of the additional output from Iraq and Kuwait has been stranded behind blocked shipping lanes, rendering nominal quota increases less effective in practice. US shale production, running near 13.65 million barrels per day, provides a partial offset but cannot fully replace lost Middle Eastern barrels due to quality differences and longer transit times. On the demand side, China's crude imports have weakened considerably as refinery runs slow, and European manufacturing remains in contraction, creating headwinds that may limit how far oil can rally on supply fears alone. The status of the US Strategic Petroleum Reserve is also critical: with the Department of Energy signaling that further emergency releases will soon end, the market is losing one of its few remaining shock absorbers.

The balance of risks remains tilted toward elevated volatility. Investors monitoring USO should track not only headline developments in the Middle East but also weekly inventory data from Cushing, tanker tracking data through the Strait of Hormuz, OPEC+ compliance figures, and the trajectory of global refining margins, which serve as a real-time barometer of the physical crude market's tightness.

AI Screener

When reviewing volatile commodity ETFs like this one, I often use Tickeron’s AI Screener to quickly scan for comparable setups across sectors. It helps surface securities based on volatility, technical signals, and performance metrics without sifting through dozens of charts manually. This approach has become a regular part of my process for identifying context around moves like the recent oil rally.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: USO

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


USO's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for USO moved out of overbought territory on July 27, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 instances where the indicator moved out of the overbought zone. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on August 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on USO as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where USO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

USO broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for USO just turned positive on August 12, 2026. Looking at past instances where USO's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

USO moved above its 50-day moving average on August 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for USO crossed bullishly above the 50-day moving average on July 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where USO advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 275 cases where USO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Industry description

The investment seeks the daily changes in percentage terms of its shares’ per share NAV to reflect the daily changes in percentage terms of the spot price of light, sweet crude oil delivered to Cushing, Oklahoma, as measured by the daily changes in the price of a specified short-term futures contract on light, sweet crude oil called the “Benchmark Oil Futures Contract,” plus interest earned on USO’s collateral holdings, less USO’s expenses. USO seeks to achieve its investment objective by investing primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
View a ticker or compare two or three
USO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category CommoditiesBroadBasket

Profile
Details
Category
Commodities Focused
Address
1320 Harbor Bay ParkwaySuite 145Almadeda
Phone
403-233-9366
Web
www.unitedstatesoilfund.com
Interact to see
Advertisement
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Coca-Cola (KO) reports Q4 2025 earnings on February 10, 2026, with consensus EPS of $0.56 and revenue of $12.05 billion. PepsiCo (PEP) beat Q4 2025 estimates on February 3, reporting adjusted EPS of $2.26 (vs. $2.24 expected) and revenue of $29.34 billion.
(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.